BIOPROCURE AND PRENDIO ANNOUNCE STRATEGIC GROWTH INVESTMENT FROM PRIMUS CAPITAL
Oct 18, 2023
Posted by Prendio LLC
Genoskin Launches VaxSkin®: A Service Offering to Advance Vaccine Development
Oct 17, 2023
Posted by Genoskin
BioIVT Elevates Cell and Gene Therapy to an Artform at Meeting on the Mesa
Oct 03, 2023
Posted by BioIVT